Managing self-injection difficulties in patients with relapsing-remitting multiple sclerosis.


Difficulties with self-injection, including inabillity to self-inject, are common for individuals taking home-administered injectable medications. In relapsing-remitting multiple sclerosis (MS), all of the currently available disease-modifying medications are injectables marketed for self-injection. Problems with self-injection pose a barrier to treatment… (More)


  • Presentations referencing similar topics